期刊
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 67, 期 12, 页码 2974-2975出版社
OXFORD UNIV PRESS
DOI: 10.1093/jac/dks323
关键词
antibiotics; foot ulceration; MRSA; outpatient therapy
An audit was performed to determine whether linezolid (Zyvox, Pharmacia Limited, Sandwich, UK) was being used in accordance with local guidelines and if this had an effect on admissions for diabetes foot ulceration. Seven hundred and four patient records from 2005 to 2010 in the Diabetes Foot Clinic, Royal Infirmary of Edinburgh were audited for methicillin-resistant Staphylococcus aureus (MRSA) infections, admissions and antibiotic use. Seventeen percent (n119) of patients had proven MRSA infections. Of these, 28 (n33) were prescribed linezolid, 94 (n31) for up to 14 days and none for 28 days. Eight (24) had repeated courses. Ninety-one percent (n30) either avoided admission or were discharged early with resolution of infection. Four out of 33 patients had reversible blood abnormalities. The total cost for linezolid over this period was 58000. However, 420 bed days, costing 500/day, were avoided, producing a total saving of 210000 on inpatient costs. Linezolid guidelines reduced lengths of stay, inpatient costs and overuse of this expensive but effective treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据